[{"indications": "Indications\u00a0mild to moderate essential hypertension alone\r\nor with thiazide therapy and severe hypertension resistant to other\r\ntreatment; congestive heart failure with left ventricular dysfunction\r\n(adjunct\u2014see section 2.5.5); following\r\nmyocardial infarction, see dose; diabetic nephropathy (microalbuminuria\r\ngreater than 30\u00a0mg/day) in type 1 diabetes", "name": "CAPTOPRIL With diuretic", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.5 Hypertension and heart failure", "2.5.5 Drugs affecting the renin-angiotensin system", "2.5.5.1 Angiotensin-converting enzyme inhibitors", "CAPTOPRIL", "With diuretic"], "cautions": "Cautions\u00a0\n(From 2.5.5.1 Angiotensin-converting enzyme inhibitors: British National Formulary)\nCautions\u00a0ACE inhibitors need to be initiated with care in patients receiving diuretics (important: see Concomitant diuretics, below); first doses can cause hypotension especially in patients taking high doses of diuretics, on a low-sodium diet, on dialysis, dehydrated, or with heart failure (see above). They should also be used with caution in peripheral vascular disease or generalised atherosclerosis owing to risk of clinically silent renovascular disease; for use in pre-existing renovascular disease, see Renal Effects above. The risk of agranulocytosis is possibly increased in collagen vascular disease (blood counts recommended). ACE inhibitors should be used with care in patients with severe or symptomatic aortic stenosis (risk of hypotension) and in hypertrophic cardiomyopathy. They should also be used with care (or avoided) in those with a history of idiopathic or hereditary angioedema. If jaundice or marked elevations of hepatic enzymes occur during treatment then the ACE inhibitor should be discontinued\u2014risk of hepatic necrosis (see also Hepatic impairment, below). Interactions: Appendix 1 (ACE inhibitors).Anaphylactoid reactions\u00a0To prevent anaphylactoid reactions, ACE inhibitors should be avoided during dialysis with high-flux polyacrylonitrile membranes and during low-density lipoprotein apheresis with dextran sulphate; they should also be withheld before desensitisation with wasp or bee venom.Concomitant diuretics\u00a0ACE inhibitors can cause a very rapid fall in blood pressure in volume-depleted patients; treatment should therefore be initiated with very low doses. If the dose of diuretic is greater than 80\u00a0mg furosemide or equivalent, the ACE inhibitor should be initiated under close supervision and in some patients the diuretic dose may need to be reduced or the diuretic discontinued at least 24\u00a0hours beforehand (may not be possible in heart failure\u2014risk of pulmonary oedema). If high-dose diuretic therapy cannot be stopped, close observation is recommended after administration of the first dose of ACE inhibitor, for at least 2 hours or until the blood pressure has stabilised.", "side-effects": "Side-effects\u00a0see notes above; tachycardia, serum sickness,\r\nweight loss, stomatitis, maculopapular rash, photosensitivity, flushing\r\nand acidosis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2582.htm", "doses": ["Hypertension, used alone, initially 12.5\u00a0mg twice daily;\r\nif used in addition to diuretic (see notes above),\r\nor in elderly, initially 6.25\u00a0mg twice daily (first dose at bedtime);\r\nusual maintenance dose 25\u00a0mg twice daily; max. 50\u00a0mg twice daily (rarely\r\n3 times daily in severe hypertension)", "Heart failure (adjunct), initially 6.25\u201312.5\u00a0mg 2\u20133 times daily\r\nunder close medical supervision (see notes above),\r\nincreased gradually at intervals of at least 2 weeks up to max. 150\u00a0mg\r\ndaily in divided doses if tolerated", "Prophylaxis after infarction in clinically stable patients with\r\nasymptomatic or symptomatic left ventricular dysfunction (radionuclide\r\nventriculography or echocardiography undertaken before initiation),\r\ninitially 6.25\u00a0mg, starting as early as 3 days after infarction, then\r\nincreased over several weeks to 150\u00a0mg daily (if tolerated) in divided\r\ndoses", "Diabetic nephropathy, 75\u2013100\u00a0mg daily in divided doses; if further\r\nblood pressure reduction required, other antihypertensives may be\r\nused in conjunction with captopril; in severe renal\r\nimpairment, initially 12.5\u00a0mg twice daily (if concomitant diuretic\r\ntherapy required, loop diuretic rather than thiazide should be chosen)", "Name[Capozide\u00ae (Squibb) ] Tablets, scored, co-zidocapt 25/50\r\n(hydrochlorothiazide 25\u00a0mg, captopril 50\u00a0mg), net price 30-tab pack = \u00a37.02"], "pregnancy": "Pregnancy\u00a0\n(From 2.5.5.1 Angiotensin-converting enzyme inhibitors: British National Formulary)\nPregnancy\u00a0ACE inhibitors should be avoided in pregnancy unless essential. They may adversely affect fetal and neonatal blood pressure control and renal function; skull defects and oligohydramnios have also been reported."}, {"indications": "Indications\u00a0mild to moderate essential hypertension alone\r\nor with thiazide therapy and severe hypertension resistant to other\r\ntreatment; congestive heart failure with left ventricular dysfunction\r\n(adjunct\u2014see section 2.5.5); following\r\nmyocardial infarction, see dose; diabetic nephropathy (microalbuminuria\r\ngreater than 30\u00a0mg/day) in type 1 diabetes", "name": "CAPTOPRIL", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.5 Hypertension and heart failure", "2.5.5 Drugs affecting the renin-angiotensin system", "2.5.5.1 Angiotensin-converting enzyme inhibitors"], "cautions": "Cautions\u00a0\n(From 2.5.5.1 Angiotensin-converting enzyme inhibitors: British National Formulary)\nCautions\u00a0ACE inhibitors need to be initiated with care in patients receiving diuretics (important: see Concomitant diuretics, below); first doses can cause hypotension especially in patients taking high doses of diuretics, on a low-sodium diet, on dialysis, dehydrated, or with heart failure (see above). They should also be used with caution in peripheral vascular disease or generalised atherosclerosis owing to risk of clinically silent renovascular disease; for use in pre-existing renovascular disease, see Renal Effects above. The risk of agranulocytosis is possibly increased in collagen vascular disease (blood counts recommended). ACE inhibitors should be used with care in patients with severe or symptomatic aortic stenosis (risk of hypotension) and in hypertrophic cardiomyopathy. They should also be used with care (or avoided) in those with a history of idiopathic or hereditary angioedema. If jaundice or marked elevations of hepatic enzymes occur during treatment then the ACE inhibitor should be discontinued\u2014risk of hepatic necrosis (see also Hepatic impairment, below). Interactions: Appendix 1 (ACE inhibitors).Anaphylactoid reactions\u00a0To prevent anaphylactoid reactions, ACE inhibitors should be avoided during dialysis with high-flux polyacrylonitrile membranes and during low-density lipoprotein apheresis with dextran sulphate; they should also be withheld before desensitisation with wasp or bee venom.Concomitant diuretics\u00a0ACE inhibitors can cause a very rapid fall in blood pressure in volume-depleted patients; treatment should therefore be initiated with very low doses. If the dose of diuretic is greater than 80\u00a0mg furosemide or equivalent, the ACE inhibitor should be initiated under close supervision and in some patients the diuretic dose may need to be reduced or the diuretic discontinued at least 24\u00a0hours beforehand (may not be possible in heart failure\u2014risk of pulmonary oedema). If high-dose diuretic therapy cannot be stopped, close observation is recommended after administration of the first dose of ACE inhibitor, for at least 2 hours or until the blood pressure has stabilised.", "side-effects": "Side-effects\u00a0see notes above; tachycardia, serum sickness,\r\nweight loss, stomatitis, maculopapular rash, photosensitivity, flushing\r\nand acidosis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2579.htm", "doses": ["Hypertension, used alone, initially 12.5\u00a0mg twice daily;\r\nif used in addition to diuretic (see notes above),\r\nor in elderly, initially 6.25\u00a0mg twice daily (first dose at bedtime);\r\nusual maintenance dose 25\u00a0mg twice daily; max. 50\u00a0mg twice daily (rarely\r\n3 times daily in severe hypertension)", "Heart failure (adjunct), initially 6.25\u201312.5\u00a0mg 2\u20133 times daily\r\nunder close medical supervision (see notes above),\r\nincreased gradually at intervals of at least 2 weeks up to max. 150\u00a0mg\r\ndaily in divided doses if tolerated", "Prophylaxis after infarction in clinically stable patients with\r\nasymptomatic or symptomatic left ventricular dysfunction (radionuclide\r\nventriculography or echocardiography undertaken before initiation),\r\ninitially 6.25\u00a0mg, starting as early as 3 days after infarction, then\r\nincreased over several weeks to 150\u00a0mg daily (if tolerated) in divided\r\ndoses", "Diabetic nephropathy, 75\u2013100\u00a0mg daily in divided doses; if further\r\nblood pressure reduction required, other antihypertensives may be\r\nused in conjunction with captopril; in severe renal\r\nimpairment, initially 12.5\u00a0mg twice daily (if concomitant diuretic\r\ntherapy required, loop diuretic rather than thiazide should be chosen)"], "pregnancy": "Pregnancy\u00a0\n(From 2.5.5.1 Angiotensin-converting enzyme inhibitors: British National Formulary)\nPregnancy\u00a0ACE inhibitors should be avoided in pregnancy unless essential. They may adversely affect fetal and neonatal blood pressure control and renal function; skull defects and oligohydramnios have also been reported."}]